Esculentoside A
CAS: 65497-07-6
Ref. TM-T3877
1mg | 35.00 € | ||
5mg | 69.00 € | ||
10mg | 109.00 € | ||
25mg | 198.00 € | ||
50mg | 298.00 € | ||
100mg | 441.00 € | ||
1ml*10 (DMSO) | 95.00 € |
Product Information
- (2b,3b,4a,20b)-3-((4-O-beta-D-Glucopyranosyl-beta-D-xylopyranosyl)oxy)-2,23-dihydroxyolean-12-ene-28,29-dioic acid 29-methyl ester
- 3-O-(4-O-β-<span class="text-smallcaps">D</smallcap>-Glucopyranosyl-β-<smallcap>D</span>-xylopyranosyl)phytolaccagenin
- 4-O-(2,23,28-trihydroxy-29-methoxy-28,29-dioxoolean-12-en-3-yl)pentopyranosyl hexopyranoside
- Olean-12-ene-28,29-dioic acid, 3-[(4-O-β-<span class="text-smallcaps">D</smallcap>-glucopyranosyl-β-<smallcap>D</span>-xylopyranosyl)oxy]-2,23-dihydroxy-, 29-methyl ester, (2β,3β,4α,20β)-
- Phytolaccagenin, 3-(4-O-β-<span class="text-smallcaps">D</smallcap>-glucopyranosyl-β-<smallcap>D</span>-xylopyranoside)
- Phytolaccasaponin E
- Phytolaccoside E
Esculentoside A can suppress inflammatory responses in LPS-induced ALI through inhibition of the NF-κB and mitogen-activated protein kinase signaling pathways. Esculentoside A may be useful for the treatment of autoimmune disease through modulation on T cell-mediated adaptive immunity. Esculentoside A may play significant roles in the treatment of BXSB mice through modulation of inflammatory cytokines, inhibition of renal cell proliferation and induction of apoptosis.
Chemical properties
Technical inquiry about: TM-T3877 Esculentoside A
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.